Taste dysfunction rises steeply at lower tongue mucosal doses during head and neck IMRT
In 32 head and neck cancer patients, taste dysfunction increased nonlinearly with cumulative tongue mucosal dose, without a validated 20-Gy threshold.
In 32 head and neck cancer patients, taste dysfunction increased nonlinearly with cumulative tongue mucosal dose, without a validated 20-Gy threshold.
All 13 CNS germinoma patients remained event-free at five years after upfront RT, but treatment-sequencing comparisons in nongerminomatous tumors remain inconclusive.
In a 23-patient phase I study, five-fraction partial-breast SBRT produced no in-breast recurrences, while favorable cosmesis declined to 73.7% at three years.
Conditioned medium from proton-irradiated chondrosarcoma cells reduced survival to 79% in chondrocytes and 59% in endothelial-like cells under different dose conditions.
All ten children completed upright proton therapy, including craniospinal irradiation, with no in-field progression at three months but limited long-term follow-up.
At 8 Gy, astrocyte injury was approximately 35% with FLASH versus 65% with conventional irradiation, alongside persistent glioma-cell metabolic stress.
Before mask fabrication, 44% of 39 head and neck cancer patients screened positive for clinically meaningful anxiety; screening took a median 3.6 minutes.
In 60 patients with postradiation skull-base osteoradionecrosis, ultrasound-guided flap reconstruction showed approximately 93–95% survival, with prolonged surgery associated with necrosis.
A heavily pretreated patient with metastatic dedifferentiated osteosarcoma received three spinal radiotherapy courses, achieving a temporary response despite subsequent neurological complications and progression.
In 26 randomized cervical cancer patients, hyaluronic acid spacer injection did not significantly reduce rectal D2cm³ during MRI-guided adaptive brachytherapy.
In 57 patients with low rectal cancer, neoadjuvant chemoradiotherapy and consolidation CAPOX achieved 61.4% pathological complete response and 94.7% sphincter preservation.
A retrocrural nodal lesion regressed after 42 Gy in three fractions, with AFP normalization and no radiological disease at 15 months.
In 18 evaluable patients, papaverine combined with lung SBRT achieved 100% estimated two-year local control, with two dose-limiting toxicities.
In 57 evaluable patients, Gamma Knife thalamotomy improved tremor assessments in 84%, while 26.5% of those with clinical follow-up reported adverse effects.
Among 30 men with unfavorable-risk prostate cancer, single-fraction 24 Gy RT plus ADT produced 100% two-year biochemical control without grade ≥3 toxicity.